Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP985070.RAFCRL_O_VuDItopb2S_vzYO04alE4oZSp5hkykuRl-7I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP985070.RAFCRL_O_VuDItopb2S_vzYO04alE4oZSp5hkykuRl-7I130_assertion type Assertion NP985070.RAFCRL_O_VuDItopb2S_vzYO04alE4oZSp5hkykuRl-7I130_head.
- NP985070.RAFCRL_O_VuDItopb2S_vzYO04alE4oZSp5hkykuRl-7I130_assertion description "[We developed three new cell lines from HER2 gene-amplified gastric cancer cell lines (GLM-1, GLM-4, NCI N-87) by a new in vivo selection method consisting of the repeated culture of small residual peritoneal metastasis but not subcutaneous tumor after Tmab treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP985070.RAFCRL_O_VuDItopb2S_vzYO04alE4oZSp5hkykuRl-7I130_provenance.
- NP985070.RAFCRL_O_VuDItopb2S_vzYO04alE4oZSp5hkykuRl-7I130_assertion evidence source_evidence_literature NP985070.RAFCRL_O_VuDItopb2S_vzYO04alE4oZSp5hkykuRl-7I130_provenance.
- NP985070.RAFCRL_O_VuDItopb2S_vzYO04alE4oZSp5hkykuRl-7I130_assertion SIO_000772 23948998 NP985070.RAFCRL_O_VuDItopb2S_vzYO04alE4oZSp5hkykuRl-7I130_provenance.
- NP985070.RAFCRL_O_VuDItopb2S_vzYO04alE4oZSp5hkykuRl-7I130_assertion wasDerivedFrom befree-20150227 NP985070.RAFCRL_O_VuDItopb2S_vzYO04alE4oZSp5hkykuRl-7I130_provenance.
- NP985070.RAFCRL_O_VuDItopb2S_vzYO04alE4oZSp5hkykuRl-7I130_assertion wasGeneratedBy ECO_0000203 NP985070.RAFCRL_O_VuDItopb2S_vzYO04alE4oZSp5hkykuRl-7I130_provenance.